Answers are grounded in this paper and cite their sources.
Chromatographic separation of the ethanol extract of the starfish Distolasterias nipon yielded one new asterosaponin, nipoglycoside E (1), together with four known asterosaponins (2–5) and one known native asterosapogenin (6). The structure of nipoglycoside E (1) was elucidated by NMR and ESI-MS analyses combined with chemical transformations and assigned as 6-O-{β-D-fucopyranosyl-(1→2)-β-D-xylopyranosyl-(1→4)-[β-D-quinovopyranosyl-(1→2)]-β-D-quinovopyranosyl-(1→3)-β-D-quinovopyranosyl}-6α-hydroxy-5α-pregn-9(11)-en-20-one-3β-yl sulphate. Notably, all isolated metabolites possess a shortened pregnane-type side chain in their steroidal aglycones. This contrasts with previous reports from D. nipon, in which only asterosaponins bearing a cholestane-type side chain had been identified. At concentrations of up to 100 μM, compounds 1–6 showed no antimicrobial activity against Staphylococcus aureus, Escherichia coli, or Candida albicans, and did not inhibit urease activity. In contrast, all isolated compounds exerted significant anti-inflammatory and cardioprotective effects in TNF-α-stimulated H9c2 cardiomyocytes. Among the tested compounds, pectinioside D (5) showed the highest activity, although the differences among the compounds were modest.
No takes yet. Share an insight, caveat, or question.
Arkhangelskaya et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: